Intra-Cellular Therapies, Inc(NASDAQ:ITCI) 
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It i...
Founded: 2002
Full Time Employees: 330
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-08-30
P
O 72.27
H 73.48
L 72.20
C 73.28
V 603,112
10EMA 73.28
20EMA 73.28
60EMA 73.28
120EMA 73.28
250EMA 73.28